Table 2.
Outcome | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 |
---|---|---|---|---|---|---|---|
Pain intensity | |||||||
R2 | 0.312 | 0.362 | 0.405 | 0.489 | 0.496 | 0.514 | 0.531 |
ΔR2 | -- | 0.046 | 0.043 | 0.085 | 0.007 | 0.018 | 0.017 |
Pain interference | |||||||
R2 | 0.330 | 0.343 | 0.374 | 0.498 | 0.512 | 0.520 | 0.540 |
ΔR2 | -- | 0.013 | 0.031 | 0.124 | 0.013 | 0.008 | 0.020 |
Pain intensity* | |||||||
R2 | 0.245 | 0.288 | 0.348 | 0.463 | 0.471 | 0.493 | 0.510 |
ΔR2 | -- | 0.042 | 0.060 | 0.116 | 0.008 | 0.022 | 0.017 |
Pain interference* | |||||||
R2 | 0.254 | 0.264 | 0.307 | 0.479 | 0.500 | 0.509 | 0.524 |
ΔR2 | -- | 0.010 | 0.043 | 0.172 | 0.018 | 0.012 | 0.015 |
Model 1: Disease-related factors; Model 2: Model 1 + demographic factors; Model 3: Model 2 + socioeconomic factors; Model 4: Model 3 + physical factors; Model 5: Model 4 + psychological factors; Model 6: Model 5 + behavioral factors; Model 7: Model 6 + social factors.
These models comprise the sensitivity analyses that include the modified Systemic Lupus Activity Questionnaire (SLAQ) which removes overt mentions of pain including stomach pain, chest pain, headache, joint swelling, joint pain, muscle pain